Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
MARKSANS Stock Analysis
Views
Red Flags
Positive
Stock is reasonably valued and PE TTM is at a discount to industry median
Analysts have been raising forward EPS estimates
High and stable operating margin
Moderate revenue growth and above median growth of industry
Low Debt to Equity, not much change from last year
Consistently pays dividend
Company is net cash
Negative
Weak price momentum
Moderate ROE but declining trend
Low EPS growth and lower than median growth of industry
Low dividend yield
Neutral
Company's earnings are of moderate quality
No red flags found!
No significant red flags found in the stock.
Snapshot
See detailed analysis
MARKSANS Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
MARKSANS Bulk, Block & Insider Trades
MARKSANS Dividends, Splits & Bonus
Dividend Events
Capital Change Events
Stock split
Others
Stock split(1 : 10)Nominal value change from Rs. 10.00 to Rs. 1.00 Ex-date: 11th Mar 2008 Announced on: 25th Jan 2008
Merger Ex-date: 18th Oct 2005 Announced on: 19th Aug 2005
Company Profile
Marksans Pharma Limited is an India-based company, which is primarily engaged in the business of research, manufacture, marketing and sale of pharmaceutical formulations. It operates two manufacturing facilities in Goa and maintains two research and development centers, one located in Goa and the ot... Read More
Key personnel
Mr. Mark B. SaldanhaD
Executive Chairman of the Board, Managing Director
Mr. Jitendra Sharma
Group Chief Financial Officer
Mr. Harshavardhan Panigrahi
Company Secretary, Compliance Officer
Mr. Sathish Kumar
Managing Director - UK Operations
Mr. David Mohammed
Managing Director - Australia Operations
Mr. Varddhman Vikramaditya JainD
Whole Time Director
Mrs. Sandra SaldanhaD
Whole Time Director
Mr. Anjani Kumar
Chief Operating Officer - US Operations
View all
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Marksans Pharma Ltd.?
The current share price of Marksans Pharma Ltd. is ₹ 173.96 as of 09 Jan 2026.
What is the PE ratio of Marksans Pharma Ltd.?
The Price-to-Earnings (PE) ratio of Marksans Pharma Ltd. is 22.36 as of the latest financial data.
What is the ROE and ROCE of Marksans Pharma Ltd.?
Marksans Pharma Ltd. has a Return on Equity (ROE) of 14.19% and a Return on Capital Employed (ROCE) of 14.93% as per the latest financial reports.
What is the market cap of Marksans Pharma Ltd.?
The market capitalization of Marksans Pharma Ltd. stands at ₹ 7,883.24 Cr.
What is the dividend yield of Marksans Pharma Ltd.?
The dividend yield of Marksans Pharma Ltd. is 0.46% based on the current market price.
What is the RSI of Marksans Pharma Ltd.?
The Relative Strength Index (RSI) of Marksans Pharma Ltd. is 36.96.
What is the FII and DII holding in Marksans Pharma Ltd.?
Foreign Institutional Investors (FII) hold 16.92% and Domestic Institutional Investors (DII) hold 3.92% of Marksans Pharma Ltd. shares.
What sector does Marksans Pharma Ltd. belong to?
Marksans Pharma Ltd. operates in the Healthcare sector.
What is the beta of Marksans Pharma Ltd. stock?
The beta of Marksans Pharma Ltd. stock is 1.45, indicating its volatility relative to the broader market.
